Fig. 3
From: Network integration of multi-tumour omics data suggests novel targeting strategies
Gene signature and survival outcome. Kaplan–Meier survival curves for two groups of patients obtained via k-mean clustering of expression levels of cluster 2 signature genes. a Plot of the survival curves for worse (group 0) and better (group 1) outcome patient groups of all cluster 2 tumours, with a 95% confidence interval (group 0: 790 observations, 362 censored; group 1: 1094 observations, 648 censored; log-rank test p-value: 7.26 × 10−18). b Distribution of group 0 and group 1 patients inside cluster 2 tumours, showing a fairly homogeneous distribution of samples (see Supplementary Table 10 for further discussion). c–h Kaplan–Meier survival curves for groups 0 and 1 considering each tumour separately
